Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults

On May 28th, CDPH issued a Health Advisory about reported cases of myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines among adolescents and young adults, which are being investigated by the CDC. COVID-19 immunization is still recommended for persons 12 years of age and older. All cases of myocarditis following receipt of COVID-19 vaccine, as well as other adverse events following vaccination, should be reported promptly to the CDC/FDA Vaccine Adverse Event Reporting System (VAERS)

Terms of Use  |  Privacy